BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $18
Replimune Group Analyst Ratings
H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17
J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Cuts Target Price to $16
BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14
Barclays Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17
H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17
Replimune Group Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Replimune Group, Maintains $17 Price Target
Replimune Group Is Maintained at Overweight by JP Morgan
Replimune Group Analyst Ratings
J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $17
Jefferies Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $16
Jefferies Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $16
HC Wainwright & Co. Reiterates Buy on Replimune Group, Maintains $17 Price Target
H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17
Barclays Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17
BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14
Replimune Group Analyst Ratings
H.C. Wainwright Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $17